Conquering Diseases

Study Of Longer-Term Caffeine Treatment For Apnea (Pauses In Breathing) In Preterm Infants

Description

Preterm Infants diagnosed with pauses in breathing (apnea of prematurity) and treated for intermittent hypoxia using caffeine sought for study of longer-term caffeine treatment

Overview

We are studying whether continuing caffeine treatment for pre-term infants with apnea of prematurity (pauses in breathing) for an additional 7 to 10 weeks after when treatment would usually end helps to prevent drops in oxygen levels in the blood (intermittent hypoxia)

What we're hoping for

We hope to get a better sense of when would be the best time to stop treating pre-term infants with caffeine to prevent pauses in breathing that may result in drops in oxygen levels in their blood

Additional Information

ClinicalTrials.gov Identifier: NCT03321734

 Principal Investigator

Lawrence  Rhein, MD, MPH

UMass Memorial Health Care

 Study Contact

Heather  White

508-334-8063

Heather.White@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989